NeuroPace, Inc. (NPCE)
13.99
-0.04
(-0.29%)
USD |
NASDAQ |
Aug 24, 16:00
13.99
0.00 (0.00%)
After-Hours: 20:00
NeuroPace Profit Margin (Quarterly) : -27.16% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -27.16% |
| March 31, 2026 | -30.31% |
| December 31, 2025 | -10.26% |
| September 30, 2025 | -12.78% |
| June 30, 2025 | -51.36% |
| March 31, 2025 | -29.25% |
| December 31, 2024 | -24.46% |
| September 30, 2024 | -25.89% |
| June 30, 2024 | -39.02% |
| March 31, 2024 | -49.24% |
| December 31, 2023 | -34.42% |
| September 30, 2023 | -44.18% |
| June 30, 2023 | -55.26% |
| Date | Value |
|---|---|
| March 31, 2023 | -71.69% |
| December 31, 2022 | -87.15% |
| September 30, 2022 | -105.6% |
| June 30, 2022 | -124.4% |
| March 31, 2022 | -100.8% |
| December 31, 2021 | -97.24% |
| September 30, 2021 | -78.18% |
| June 30, 2021 | -67.25% |
| March 31, 2021 | -78.54% |
| December 31, 2020 | -42.95% |
| September 30, 2020 | -32.31% |
| June 30, 2020 | -115.1% |
| March 31, 2020 | -67.58% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | -8.33% |
| CVRx, Inc. | -89.42% |
| Accuray, Inc. | -1.92% |
| Orthofix Medical, Inc. | -7.49% |
| ResMed, Inc. | 26.20% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -114.7% |
| Return on Assets | -15.84% |
| Return on Invested Capital | -21.86% |
| Gross Profit Margin (Quarterly) | 82.83% |
| Operating Margin (Quarterly) | -22.53% |
| Return on Net Operating Assets | -44.33% |